Holland Johnson

Atlanta

Executive Editor at BioWorld

Executive Editor of Medical Device Daily, the daily medical technology news source. Lover of all things Georgia Bulldog-related. Avid outdoor enthusiast.

Featured in: Favicon

bioworld.com

Articles

J&J reports completion of first cases with Ottava robotic system

1 week ago | bioworld.com | Holland Johnson

J&J reports completion of first cases with Ottava robotic systemJohnson & Johnson’s Medtech division reported the completion of the first cases in the clinical trial for the Ottava robotic surgical system. The cases mark the first clinical experience with the Ottava system, which has been a long time in development. BioWorld MedTech Clinical Regulatory Gastrointestinal Robotic surgery U.S. De novo FDA
Vivani looking to get slim with Cortigent neurostimulation spin

1 month ago | bioworld.com | Holland Johnson

Home » Vivani looking to get slim with Cortigent neurostimulation spinVivani looking to get slim with Cortigent neurostimulation spinThe Vivani Medical Inc. combination appears to be over less than three years since its inception after the company reported plans to spin off Cortigent, the division that develops brain implants. BioWorld Deals and M&A Diabetes Neurology/psychiatric Deep brain stimulation U.S.
Vivani looking to slim with Cortigent neurostimulation spin

1 month ago | bioworld.com | Holland Johnson

At the 2025 meeting of the Conference on Retroviruses and Opportunistic Infections (CROI) it was the best of times, it was the worst of times. On the first full...
SCAAR data Prevails for Medtronic paclitaxel-coated balloon

1 month ago | bioworld.com | Holland Johnson

SCAAR data Prevails for Medtronic paclitaxel-coated balloonMedtronic plc reported results from a registry highlighting the effectiveness of the Prevail paclitaxel-coated balloon. The findings from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR) were presented by Sacharias von Koch of the department of cardiology and clinical sciences at Lund University, Skåne University Hospital in Sweden at the Cardiovascular Research Technologies 2025 meeting in Washington.
Medtronic sees SMART TAVR results in small aortic annulus patients

1 month ago | bioworld.com | Holland Johnson

Medtronic sees SMART TAVR results in small aortic annulus patientsMedtronic plc released positive results from a two-year trial of Evolut TAVR that demonstrated superior valve performance in patients with small aortic annuli. The SMall Annuli Randomized To Evolut or SAPIEN trial assessed patients with aortic stenosis and a small aortic annulus.
Repligen buying 908 Devices’ Bioprocess Analytics portfolio

1 month ago | bioworld.com | Holland Johnson

Home » Repligen buying 908 Devices’ Bioprocess Analytics portfolio On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his... BioWorld briefs for March 6, 2025. BioWorld MedTech briefs for March 5, 2025 Roche Holding AG revealed plans to launch its sequencing by expansion technology next year, raising the possibility that rival Illumina Inc. could face a real run...
Tandem wins FDA clearance for automated insulin delivery system

1 month ago | bioworld.com | Holland Johnson

Tandem wins FDA clearance for automated insulin delivery systemTandem Diabetes Care Inc. reported that its next-generation automated insulin delivery algorithm, Control-IQ+ technology (Control-IQ+), is cleared by the U.S. FDA for use by people with type 2 diabetes (T2D) ages 18 and older. Control-IQ+, already cleared for use by people with type 1 diabetes, builds on the company’s Control-IQ algorithm and includes enhancements to accommodate input of expanded weight and total daily insulin ranges.
Raft of FDA job cuts may slow med-tech approvals

2 months ago | bioworld.com | Holland Johnson

Raft of FDA job cuts may slow med-tech approvalsIn response to the news of reported layoffs at the U.S. FDA over the weekend, Advanced Medical Association president and CEO Scott Whitaker said in press release that these “significant job cuts could have a very negative impact on patient care in this country.”BioWorld MedTech Clinical Regulatory U.S. FDA Policy
Globus Medical buying chronic pain company Nevro for $250M

2 months ago | bioworld.com | Holland Johnson

Globus Medical buying chronic pain company Nevro for $250M Globus Medical Inc. reported it is buying Nevro Corp. in an all-cash transaction. Under the terms of the agreement, which was unanimously approved by the boards of both companies, Globus will acquire all shares of Nevro for $5.85 per share. The transaction represents a total equity value of approximately $250 million. BioWorld MedTech Deals and M&A Orthopedic implants U.S.
Boston Sci reports good data for Farapulse, Watchman afib systems

Jan 17, 2025 | bioworld.com | Holland Johnson

Boston Sci reports good data for Farapulse, Watchman afib systemsBoston Scientific Corp. reported positive data for two key atrial fibrillation therapies at AF Symposium 2025 on January 17. In late-breaking data presentations, the ADVANTAGE AF trial for the Farapulse PFA system met its primary endpoints, showing a 2.3% safety event rate and 63.5% effectiveness rate in treating persistent atrial fibrillation (AF) patients, with an 85.3% symptomatic AF recurrence-free rate.